4506.T
Sumitomo Dainippon Pharma Co Ltd
Price:  
1,032 
JPY
Volume:  
5,246,500
Japan | Pharmaceuticals

4506.T DCF Valuation - Growth Exit 5Y

-23.9 %
Upside

What is the DCF valuation of 4506.T?

The Discounted Cash Flow (DCF) valuation of Sumitomo Dainippon Pharma Co Ltd (4506.T) is 784.88 JPY. With the latest stock price at 1,032.00 JPY, the upside of Sumitomo Dainippon Pharma Co Ltd based on DCF is -23.9%.

Is 4506.T a buy or a sell?

Based on the latest price of 1,032.00 JPY and our DCF valuation, Sumitomo Dainippon Pharma Co Ltd (4506.T) is a sell. Selling 4506.T stocks now will result in a potential gain of 23.9%.

Range Selected
WACC / Discount Rate4.4% - 5.9%5.2%
Long-term Growth Rate 1.0% - 3.0%2.0%
Fair Price287.22 - 2,478.46784.88
Upside-72.2% - 140.2%-23.9%
1,032.00 JPY
Stock Price
784.88 JPY
Fair Price
REVENUE & EXPENSES
CAPEX
D&A
WORKING CAPITAL
TERMINAL VALUE

4506.T DCF Valuation: Revenue & Expenses Forecast

(JPY in millions)Projections
03-202503-202603-202703-202803-202903-2030
Revenue398,832377,466372,472387,581396,597418,002
% Growth
27%-5%-1%4%2%5%
Cost of goods sold(153,437)(145,217)(143,296)(149,108)(152,577)(160,812)
% of Revenue38%38%38%38%38%38%
Selling, G&A expenses(180,605)(170,930)(168,668)(175,510)(179,593)(189,286)
% of Revenue45%45%45%45%45%45%
Research & Development(49,865)(47,194)(46,569)(48,458)(49,586)(52,262)
% of Revenue13%13%13%13%13%13%
Net interest & other expenses2,6862,5422,5082,6102,6712,815
% of Revenue1%1%1%1%1%1%
Tax expense6,024(5,104)(5,036)(5,240)(5,362)(5,652)
Tax rate34%31%31%31%31%31%
Net profit23,63511,56411,41111,87412,15012,806
% Margin6%3%3%3%3%3%